Arbutus Biopharma Corporation - PE Ratio

The PE Ratio as of June 2026 (TTM) for Arbutus Biopharma Corporation (ABUS) is 5.48

According to Arbutus Biopharma Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 5.48. This represents a change of -172.49% compared to the average of -7.56 of the last 4 quarters.

Arbutus Biopharma Corporation (ABUS) Historical PE Ratio (quarterly & annually)

How has ABUS PE Ratio performed in the past?

The mean historical PE Ratio of Arbutus Biopharma Corporation over the last ten years is -6.55. The current 5.48 PE Ratio has changed -8469.91% with respect to the historical average. Over the past ten years (40 quarters), ABUS's PE Ratio was at its highest in in the June 2018 quarter at 182.50. The PE Ratio was at its lowest in in the December 2025 quarter at -61.67.

Arbutus Biopharma Corporation (ABUS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Arbutus Biopharma Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arbutus Biopharma Corporation (ABUS) Average PE Ratio

How has ABUS PE Ratio performed in the past?

The current PE Ratio of Arbutus Biopharma Corporation (ABUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arbutus Biopharma Corporation (ABUS) PE Ratio vs. Peers

How is ABUS’s PE Ratio compared to its peers?

Arbutus Biopharma Corporation’s PE Ratio is greater than ARS Pharmaceuticals, Inc. (-4.80), greater than Nanobiotix S.A. (-59.45), greater than GH Research PLC (-24.17), greater than Tango Therapeutics, Inc. (-33.70), greater than Bicara Therapeutics Inc. Common Stock (-8.36), greater than Septerna, Inc. (-44.65), greater than EyePoint Pharmaceuticals, Inc. (-3.88), greater than Kura Oncology, Inc. (-2.96), greater than ProKidney Corp. (-3.33), greater than Savara Inc. (-9.82),

Build a custom stock screener for Arbutus Biopharma Corporation (ABUS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arbutus Biopharma Corporation (ABUS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arbutus Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.